Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.
about
Brain Functional Effects of Psychopharmacological Treatment in Major Depression: a Focus on Neural Circuitry of Affective ProcessingPharmacological approaches to the challenge of treatment-resistant depressionDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressantsThe neuroscience of depression: implications for assessment and intervention.Predicting clinical outcome using brain activation associated with set-shifting and central coherence skills in Anorexia Nervosa.Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.Bipolar I disorder and major depressive disorder show similar brain activation during depression.Clinical predictors of ketamine response in treatment-resistant major depression.Surface vulnerability of cerebral cortex to major depressive disorder.Glutamate metabolism in major depressive disorderPretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to ScopolamineFusiform Gyrus Dysfunction is Associated with Perceptual Processing Efficiency to Emotional Faces in Adolescent Depression: A Model-Based Approach.Human biomarkers of rapid antidepressant effectsMechanisms of antidepressant resistanceReduced intrinsic connectivity of amygdala in adults with major depressive disorder.Alterations in visual cortical activation and connectivity with prefrontal cortex during working memory updating in major depressive disorder.New paradigms for treatment-resistant depressionToward the application of functional neuroimaging to individualized treatment for anxiety and depression.Anomalous single-subject based morphological cortical networks in drug-naive, first-episode major depressive disorder.A dual process for the cognitive control of emotional significance: implications for emotion regulation and disorders of emotion.Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder.Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder.Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.Neural predictors of 12-month weight loss outcomes following bariatric surgery.Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.A spectroscopic approach toward depression diagnosis: local metabolism meets functional connectivity.The P1 visual-evoked potential, red light, and transdiagnostic psychiatric symptoms.Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine AdministrationEffects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder
P2860
Q26786234-750B9B35-3A7C-4853-8ADB-601FFEE9F33DQ26798241-F4168556-C372-426D-944D-C58FF5ED4D75Q26996955-E714DCD6-229B-4080-86D0-7655D3F83FEDQ30399725-EED2EAB4-0332-452A-BF7C-9576AD38377AQ34022807-D0B26437-78D0-4DEA-A1F0-650213C553FFQ34181837-5436E166-245D-4250-9165-5B04744B875BQ34421952-A0012045-2828-4C6F-9051-76CE5E938CE4Q35026766-23E5EBE7-5A31-434B-A8BB-3FAB85646BCBQ35203483-3322B447-E8F2-435E-84A1-09B5516C1BD5Q35756139-017C727B-E4DF-409F-86F0-AB0BCD49DF5EQ36064491-02E7BA4B-DA67-4000-A051-7AE8B63CF103Q36542855-8D4758E3-9198-4786-B804-0B48924F48C8Q36902074-A76ABD2F-77A1-45D7-A0B6-585C94C75F9AQ37334088-2EDFB890-58AA-4F68-BD20-D6F90793DCC8Q37592088-8A883A8B-77F9-4E19-8CAE-D2E211776011Q37600718-B4E17056-E2D0-4658-916C-5E1E827E466CQ37607004-5ACF75C5-F8F4-4C45-9047-922508C99CF1Q38269358-A2A0C9B6-81AE-46F5-B0AC-26156C00A342Q38972847-256B9A70-40B4-4DE1-9AFB-C3833E6E4B41Q39134872-D93D6DC6-6C2D-4A17-96D6-E2E9FD756688Q39642484-7E41A487-A67F-4F66-9B44-55CE06751D28Q39796029-6314ED09-0E43-4C8A-9BF1-BE346B892C62Q41753839-195D50CB-B82F-48FA-9E17-5B1ADAADDFCDQ47188658-23256A28-517C-4F8E-948A-6787C301D664Q47192906-D20C6767-45A2-46D1-8F58-4FC0BDA1F1A3Q48043918-A6B2318D-EABF-4D99-B1F1-F6D248C2D545Q52671686-FE584A1E-8DF0-495A-8854-42E1BC6EA8C4Q57461576-D6E245C2-D526-495D-BA0E-9A216E9E512FQ57477429-08DB4FE9-21E4-4719-A441-2DE1E4C9FC4A
P2860
Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential of pretreatment neur ...... in major depressive disorder.
@en
Potential of pretreatment neur ...... in major depressive disorder.
@nl
type
label
Potential of pretreatment neur ...... in major depressive disorder.
@en
Potential of pretreatment neur ...... in major depressive disorder.
@nl
prefLabel
Potential of pretreatment neur ...... in major depressive disorder.
@en
Potential of pretreatment neur ...... in major depressive disorder.
@nl
P2093
P2860
P1433
P1476
Potential of pretreatment neur ...... in major depressive disorder.
@en
P2093
Andrew M Speer
Carlos A Zarate
Elana M Hoffman
Erica Frankel
Maura L Furey
Wayne C Drevets
P2860
P304
P356
10.1001/2013.JAMAPSYCHIATRY.60
P407
P577
2013-03-01T00:00:00Z